Related Experiment Video

Updated: May 22, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Curing "incurable" cancer

James D Watson1

  • 1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA. berejka@cshl.edu

Cancer Discovery
|May 16, 2012
PubMed

Insights

Cancer cells have constantly active growth signals, making them vulnerable to anticancer drugs. RNA interference (RNAi) technologies can identify unique gene regulatory and metabolic weaknesses for more effective cancer drug targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer cells exhibit constitutively active signaling pathways essential for growth and proliferation.
  • Normal cells display regulated "on" and "off" signaling, contrasting with cancer's persistent activation.
  • Current anticancer drug discovery often targets these "always on" signals.

Purpose of the Study:

  • To explore alternative strategies for anticancer drug discovery.
  • To investigate the potential of RNA interference (RNAi) technologies.
  • To identify novel therapeutic targets by pinpointing cancer-specific vulnerabilities.

Main Methods:

  • Utilizing RNA interference (RNAi) screening to systematically analyze gene function.
  • Identifying key gene regulatory networks driving cancer cell survival.
  • Characterizing metabolic pathways critical for "always on" cancer cell phenotypes.

Main Results:

  • RNAi technologies effectively pinpointed critical gene regulatory and metabolic weaknesses in cancer cells.
  • These weaknesses represent vulnerabilities distinct from the "always on" growth signals.
  • Potential for novel therapeutic strategies targeting these identified vulnerabilities.

Conclusions:

  • Shifting focus from "always on" signals to specific regulatory and metabolic weaknesses offers a promising avenue for drug discovery.
  • RNAi is a powerful tool for uncovering these vulnerabilities.
  • Targeting these identified weaknesses could lead to more effective anticancer agents.

More Related Videos

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle12:19

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle

Published on: June 7, 2024

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...